Found 129 matching trials
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies PHASE1 This trial will look at a drug called SEA-CD70 with and without azacitidine...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia PHASE3 This randomized phase III trial studies how well imatinib mesylate works in...
Show More Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Learn More & Join Trial
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer PHASE3 This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Show More Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Learn More & Join Trial
Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma PHASE3 The purpose of the study is to determine the best treatment approach based ...
Show More Location
Beth Israel Deaconess Medical Center (BIDMC)
Learn More & Join Trial
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies PHASE2 This study will evaluate the efficacy, safety, and pharmacokinetics of mosu...
Show More Status
Active Not Recruiting
Location
Infirmary Cancer Care
Learn More & Join Trial
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma PHASE3 This phase III trial compares the effect of adding levocarnitine to standar...
Show More Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Learn More & Join Trial
Monthly Dosing of Atacicept in IgAN PHASE2 This is a Phase 2, open-label, multicenter, randomized study comprising par...
Show More Status
Active Not Recruiting
Location
Vera Therapeutics
Learn More & Join Trial
Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma PHASE3 A substance called immunoglobulin E (IgE), which is naturally produced by o...
Show More Location
Alabama Allergy and Asthma Center
Learn More & Join Trial
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) PHASE2 The main aim of this study is to learn how safe elritercept is and how well...
Show More Location
Genesis Cancer and Blood Institute
Learn More & Join Trial
ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016 PHASE2 To evaluate the outcome of a prednisolone and low dose methotrexate based p...
Show More Status
Active Not Recruiting
Location
Prince of Wales Hospital
Learn More & Join Trial